Prostate Cancer - Results from #60

Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT). September 3, 2019

Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial. September 2, 2019

A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies. September 2, 2019

Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada. September 2, 2019

Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer. September 2, 2019

[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up? September 2, 2019

Quality of Life-Focused Decision-Making for Prostate Cancer. September 2, 2019

Single Amino Acid Replacement in G-7039 Leads to a 70-Fold Increase in Binding Towards GHS-R1a. September 1, 2019

Are superior cervical sympathetic ganglia avid on whole body 68Ga-PSMA-11 PET/magnetic resonance?: a comprehensive morphologic and molecular assessment in patients with prostate cancer. September 1, 2019

Risk stratification and avoiding overtreatment in localized prostate cancer. September 1, 2019

Oncological and functional outcomes of a large Canadian robotic-assisted radical prostatectomy database with 10 years of surgical experience. September 1, 2019

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer. August 29, 2019

Treatment Response Assessment of Skeletal Metastases in Prostate Cancer with 18F-NaF PET/CT. August 29, 2019

Systemic immune-inflammation index, serum albumin, and fibrinogen impact prognosis in castration-resistant prostate cancer patients treated with first-line docetaxel. August 29, 2019

Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator. August 29, 2019

[Recurrent choroidal detachment in a patient undergoing hormone therapy for prostate cancer]. August 29, 2019

Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS. August 28, 2019

A case of metastatic prostate cancer treated with metastasectomy. August 28, 2019

Focal high-intensity focussed ultrasound partial gland ablation for the treatment of localised prostate cancer: a report of medium-term outcomes from a single-centre in the United Kingdom. August 28, 2019

Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling. August 28, 2019

Page 4 of 1003

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.